Nyxoah SA (NYXH)
8.00
-0.28
(-3.38%)
USD |
NASDAQ |
Nov 22, 16:00
7.99
-0.01
(-0.12%)
After-Hours: 20:00
Nyxoah Total Liabilities (Quarterly): 42.51M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 42.51M |
| June 30, 2024 | 30.11M |
| March 31, 2024 | 27.88M |
| December 31, 2023 | 28.89M |
| September 30, 2023 | 27.58M |
| June 30, 2023 | 29.16M |
| March 31, 2023 | 28.27M |
| December 31, 2022 | 27.61M |
| Date | Value |
|---|---|
| September 30, 2022 | 30.47M |
| June 30, 2022 | 29.91M |
| March 31, 2022 | 26.07M |
| December 31, 2021 | 25.14M |
| June 30, 2021 | 27.70M |
| March 31, 2021 | 22.45M |
| June 30, 2020 | 14.35M |
| December 31, 2019 | 14.38M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
14.35M
Minimum
Jun 2020
42.51M
Maximum
Sep 2024
27.03M
Average
27.79M
Median
Total Liabilities (Quarterly) Benchmarks
| Galapagos NV | 1.463B |
| UCB SA | 7.156B |
| Mithra Pharmaceuticals SA | 416.74M |
| Celyad Oncology SA | 12.13M |
| MDxHealth SA | 140.41M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 159.45M |
| Shareholders Equity (Quarterly) | 116.95M |
| Debt to Equity Ratio | 0.1866 |
| Current Ratio | 5.283 |
| Net Debt Paydown Yield | -0.73% |